NCI-H1437/iRFP stable cell line

NCI-H1437 iRFP cells are derived from the human NCI-H1437 lung carcinoma cell line by stably integration of a constitutive miRFP670 stably expression construct. NCI-H1437 cell line was derived from a patient with non-small cell lung carcinoma (NSCLC), and is used extensively in cancer research, particularly for studies focused on lung cancer biology, drug development, and therapeutic responses. NCI-H1437 iRFP cells stably stably express miRFP670, can be used for in vitro assays and in vivo imaging.